COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR SELECTIF DE LA TYROSINE KINASE FGFR
- 专利权人:
- LTD.;EISAI R&D MANAGEMENT CO.
- 发明人:
- SASAKI, TATSUYA,SAITO, KENICHI
- 申请号：
- CA3073398
- 公开号：
- CA3073398A1
- 申请日:
- 2018.10.10
- 申请国别(地区):
- CA
- 年份:
- 2019
- 代理人:
- 摘要：
- The present invention provides a pharmaceutical composition comprising FGFRselectivetyrosine kinase inhibitor, specifically5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridine-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-IH-indole-1-carboxamide or a pharmaceutically acceptable saltthereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Crystalline (R) - (E) -2- (4- (2- (5- (1- (3, 5 -dichloropyridin-4 -yl) ethoxy) - 1H - indazol - 3 - yl) vinyl) -1 H- pyrazol- 1 -yl) ethanol and its use as FGFR inhibitor
- CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3, 5 -DICHLOROPYRIDIN-4 -YL) ETHOXY) - 1H - INDAZOL - 3 - YL) VINYL) -1 H- PYRAZOL- 1 -YL) ETHANOL AND ITS USE AS FGFR INHIBITOR
- CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3, 5 -DICHLOROPYRIDIN-4 -YL) ETHOXY) - 1H - INDAZOL - 3 - YL) VINYL) -1 H- PYRAZOL- 1 -YL) ETHANOL AND ITS USE AS FGFR INHIBITOR
- ANNEALING PROCESS FOR A BIOABSORBABLE STENT
- COMPOSITION BASED ON BLOOD COMPOSITION ENRICHED WITH THROMBOCYTES AND/OR GROWTH FACTORS AND CONTAINS GEL-LIKE PROTEINS, AND METHOD FOR PRODUCTION THEREOF
